Oral cancer diagnosis and treatment statistics

'14-day / Two-week wait'

England meets the standard for their country on the percentage of patients first seen by a specialist within two weeks of urgent GP referral for suspected cancer.[1]

'Two-week wait' supports early diagnosis as spotting cancer early is important for improving survival, so it is important that patients with potential cancer symptoms are referred promptly.

'31-day wait'

Scotland and Northern Ireland meet the standard for their country on the percentage of patients that receive their first cancer treatment within 31 days of a decision to treat, while Wales does not meet the standard for their country.[2-4]

The speed at which patients receive their first treatment can have a positive outcome on their clinical outcome, so it is important that patients with cancer symptoms are treated promptly.

'62-day wait'

Wales, Scotland and Northern Ireland do not meet the standard for their country on the percentage of patients receiving their first definitive treatment for cancer within two months of a GP referral for suspected cancer.[2-4]

The speed at which patients receive their first treatment can have a positive outcome on their clinical outcome, so it is important that patients with cancer symptoms are treated promptly.

Cancer waiting times coding and standards are different in each country and so comparisons should not be made between countries, only each country against their own measures.

Head and Neck Cancers, Waiting Times, UK countries, 2014-15

Between 32% and 75% of patients diagnosed with head and neck cancer in England during 2013-2014 had surgery to remove their tumour, as part of their primary cancer treatment.[1] This includes patients who had surgery alone, and those who also had other treatments such as radiotherapy or chemotherapy. Surgery not intending to remove the tumour, including biopsies or other palliative surgery, is not included in this figure.

The proportion of head and neck cancer patients having surgery to remove their primary tumour is strongly influenced by stage at diagnosis.

Other factors are also important, such as whether the patient is generally well enough to tolerate the treatment, the patient’s age, and their own treatment preference.

Head and Neck Cancers (C01-04, C06-10, C12, C13, C32) Percentage of Patients Having Surgery to Remove Their Tumour Part of Their Primary Treatment, Persons, All ages, England, 2013-2014

Between 43% and 85% of patients diagnosed with head and neck cancer in England during 2013-2014 had curative or palliative radiotherapy, as part of their primary cancer treatment.[1] This includes patients who had radiotherapy alone, and those who also had other treatments such as surgery to remove the tumour, or chemotherapy.

The proportion of head and neck cancer patients having radiotherapy is strongly influenced by stage at diagnosis. 

Other factors are also important, such as whether the patient is generally well enough to tolerate the treatment, the patient’s age, and their own treatment preference.

Head and Neck Cancers (C01-04, C06-10, C12, C13, C32) Percentage of Patients Receiving Radiotherapy as Part of Their Primary Treatment, Persons, All ages, England, 2013-2014

Between 8% and 61% of patients diagnosed with head and neck cancer in England in 2013-2014 had curative or palliative chemotherapy, as part of their primary cancer treatment.[1] This includes patients who had chemotherapy alone, and those who also had other treatments such as tumour removal surgery or radiotherapy.
The proportion of head and neck cancer patients having chemotherapy is strongly influenced by stage at diagnosis. 

Other factors are also important, such as whether the patient is generally well enough to tolerate the treatment, the patient’s age, and their own treatment preference.

Head and Neck cancers (C01-04, C06-10, C12, C13, C32) Percentage of Patients Receiving Chemotherapy as Part of Their Primary Treatment, Persons, Aged All ages, England, 2013-2014

The National Cancer Patient Experience Survey monitors patients’ self-reported satisfaction with each step of the cancer pathway in England, providing information to drive improvements in cancer care.[1] The survey has been conducted annually since 2010.

Overall, most cancer patients in England report positive experiences of cancer care. However patient experience varies along the cancer pathway, and by gender, ethnicity, age, deprivation, and cancer type. Satisfaction scores tend to be higher for experiences with Clinical Nurse Specialists and other hospital staff, and lower for experiences with GPs and general practice staff. Patients who report more positive experiences of cancer diagnosis and treatment tend to be male, white, older, and less deprived.